Mayako Yamazaki

A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease

Katsuya Harada, Kazuhiro Nakato, Junko Yarimizu et al. · European Journal of Pharmacology · 2012 · 61 citations

Medicine, Neuroscience, Pharmacology +12

Changes in brain somatostatin in memory-deficient rats: comparison with cholinergic markers

Naoki Matsuoka, Mayako Yamazaki, Isamu Yamaguchi · Neuroscience · 1995 · 54 citations

Life Sciences, Neurobiology, Neuroscience +16

Novel 5-HT5A receptor antagonists ameliorate scopolamine-induced working memory deficit in mice and reference memory impairment in aged rats

Mayako Yamazaki, Noriyuki Yamamoto, Junko Yarimizu et al. · Journal of Pharmacological Sciences · 2015 · 39 citations · Full text

Medicine, Neuroscience, Pharmacology +15

Effect of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks.

Naoki Matsuoka, Noriaki Maeda, Mayako Yamazaki et al. · Journal of Pharmacology and Experimental Therapeutics · 1992 · 38 citations

Medicine, Neuroscience, Pharmacology +17

FK960 N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate ameliorates the memory deficits in rats through a novel mechanism of action.

Mayako Yamazaki, N. Matsuoka, Noriaki Maeda et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 38 citations

Medicine, Neuroscience, Pharmacology +17